4//SEC Filing
Geffken Daniel E. 4
Accession 0001213900-24-015030
CIK 0001870404other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 7:39 PM ET
Size
5.1 KB
Accession
0001213900-24-015030
Insider Transaction Report
Form 4
Geffken Daniel E.
Chief Financial Officer
Transactions
- Other
Class A Common Stock
2024-02-14+10,002→ 10,002 total
Footnotes (1)
- [F1]Represents shares of Class A Common Stock distributed in-kind by Phoenix Biotech Sponsor, LLC (the "Sponsor") to its members, pro rata and without consideration.
Documents
Issuer
CERO THERAPEUTICS HOLDINGS, INC.
CIK 0001870404
Entity typeother
Related Parties
1- filerCIK 0001314756
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 7:39 PM ET
- Size
- 5.1 KB